FEB 26, 202661 MINS READ
Ethylene vinyl acetate packaging foam is synthesized through the copolymerization of ethylene and vinyl acetate monomers, where the vinyl acetate content fundamentally governs the material's crystallinity, flexibility, and processing behavior 1. The copolymer structure consists of a polyethylene backbone with randomly distributed vinyl acetate side groups, disrupting the crystalline packing of polyethylene chains and thereby reducing crystallinity from approximately 80% (pure HDPE) to 20–50% depending on vinyl acetate concentration 16. This semi-crystalline morphology imparts a balance of elasticity and structural integrity essential for packaging applications.
Key compositional parameters include:
Vinyl Acetate Content: Typically 5–25 wt%, with higher concentrations (>15 wt%) yielding softer, more rubber-like foams suitable for cushioning, while lower concentrations (5–11 wt%) provide greater stiffness and thermal stability for structural packaging 189. Patent 8 demonstrates that EVA copolymers with 3.0–11.0 mass% vinyl acetate exhibit superior flexural moduli (1.2–2.5 GPa at 23°C) and weatherability when the compositional ratio of the lowest-mobility component (α) measured by pulsed NMR Solid Echo method is maintained at 28.0–36.0%, with relaxation times (Tγ) of 375–600 μs for the highest-mobility component.
Melt Flow Index (MFI): Ranges from 1 to 30 g/10 min (ASTM D1238, 190°C/2.16 kg), with higher MFI grades (>10 g/10 min) facilitating injection molding and extrusion processes for complex packaging geometries 16. Patent 1 specifies that foams with MFI >1 g/10 min and 5–25 wt% vinyl acetate achieve optimal cell structure uniformity and dimensional stability.
Molecular Weight Distribution: GPC-FTIR analysis reveals that controlled molecular weight distributions with slope P values of 0.00–1.40 (linear least-squares fit of carbonyl-to-methylene absorption ratio vs. log molecular weight) and mean methyl-to-methylene absorption ratios (Q) of 23.0–30.0 correlate with enhanced impact strength (>50 kJ/m² by Izod test) and environmental stress crack resistance 9.
The semi-crystalline domains act as physical crosslinks, providing shape memory and recovery after compression, while the amorphous vinyl acetate-rich regions contribute to flexibility and energy dissipation during impact events 610. This dual-phase morphology is critical for packaging foams that must withstand repeated loading cycles without permanent deformation.
The transformation of EVA copolymer resin into functional packaging foam requires precise formulation of blowing agents, crosslinking agents, fillers, and processing aids to achieve target density, cell structure, and mechanical performance 2411.
Core formulation components:
Blowing Agents: Azodicarbonamide (ADC) is the predominant chemical blowing agent, used at 3–10 parts per hundred resin (phr), decomposing at 195–215°C to release nitrogen and carbon dioxide gases that nucleate and expand foam cells 2411. Patent 2 describes ultra-soft EVA foams (10–60 Shore 00 hardness, 0.01–0.06 g/cm³ density) achieved with 2–18 phr ADC combined with precise temperature control during extrusion or compression molding. Eco-friendly alternatives such as sodium bicarbonate/citric acid systems (5–8 phr) are increasingly adopted to reduce volatile organic compound (VOC) emissions and meet REACH compliance 1214.
Crosslinking Agents: Dicumyl peroxide (DCP) at 0.3–4 phr initiates free-radical crosslinking of EVA chains at 140–180°C, forming a three-dimensional network that enhances thermal stability (heat deflection temperature increases from 45°C to 75°C), compression set resistance (<25% after 22 hours at 70°C per ASTM D395), and solvent resistance 241115. The crosslinking density must be optimized: excessive crosslinking (>4 phr DCP) yields brittle foams with poor impact absorption, while insufficient crosslinking (<0.3 phr) results in dimensional instability and creep under sustained loads.
Fillers And Reinforcements: Calcium carbonate (4–20 phr) and talc (6–15 phr) serve as nucleating agents to control cell size (10–300 μm average diameter) and reduce material cost, while natural cellulose fibers (2–8 phr) improve tear strength (>3 N/mm by ASTM D624) and provide bio-based content for sustainable packaging solutions 41118. Patent 18 reports that EVA foams with 65–70% bio-based resin (derived from sugarcane ethylene) and 2–8% cellulose fiber achieve densities of 0.3 g/cm³ and durometer readings of 65–75 (Asker-C scale), suitable for washable organizational bins and protective packaging.
Processing Aids And Stabilizers: Zinc oxide (1–5 phr) acts as a co-crosslinking agent and acid scavenger, preventing degradation of vinyl acetate groups during high-temperature processing 411. Stearic acid (1–2 phr) functions as an internal lubricant, reducing melt viscosity and improving mold release in injection molding operations 411. UV stabilizers (0.5–1.5 phr hindered amine light stabilizers) and antioxidants (0.3–1.0 phr phenolic types) are essential for outdoor packaging applications to prevent photo-oxidative yellowing and embrittlement 8.
Biodegradable formulations represent an emerging frontier: Patent 4 discloses EVA foam compositions incorporating 15–20 phr of photodegradation agents (titanium dioxide nanoparticles), chemical degradation promoters (pro-oxidant metal salts), or biodegradation enhancers (starch-based additives) that accelerate environmental breakdown after disposal while maintaining functional performance during service life. Patent 11 describes modified biodegradable EVA foams with 39.8 wt% polyhydroxybutyrate (PHB) blended with 58.7 wt% EVA, achieving 60–80% biodegradation within 180 days under composting conditions (ISO 14855 standard) without compromising initial mechanical properties (tensile strength >1.5 MPa, elongation at break >300%).
Ethylene vinyl acetate packaging foam is produced through three primary manufacturing routes—compression molding, extrusion foaming, and injection molding—each offering distinct advantages for specific packaging geometries and production scales 26714.
Compression molding is the traditional method for producing EVA foam sheets and blocks, involving the following steps 2411:
Compounding: EVA resin, blowing agent, crosslinking agent, fillers, and additives are dry-mixed or melt-compounded in a twin-screw extruder at 80–120°C (below blowing agent decomposition temperature) to produce uniform pellets or powder blends.
Preheating And Molding: The compound is loaded into a heated mold cavity (150–180°C) and compressed at 5–15 MPa for 5–15 minutes to initiate crosslinking and partial blowing agent decomposition, forming a dense precursor sheet.
Foaming: The mold is rapidly opened, and the precursor is transferred to a secondary oven at 180–220°C for 2–10 minutes, allowing full blowing agent decomposition and foam expansion to the target density (typically 0.05–0.3 g/cm³). Precise temperature control is critical: Patent 2 specifies that ultra-soft foams (0.01–0.06 g/cm³) require foaming temperatures of 195–205°C with ±3°C uniformity to prevent surface defects and density gradients.
Cooling And Post-Curing: Foamed sheets are cooled under controlled conditions (ambient air or water quench) to stabilize cell structure, followed by optional post-curing at 60–80°C for 4–24 hours to complete crosslinking reactions and reduce residual volatiles.
Process optimization strategies include the use of scorch retarders (0.5–2 phr benzoic acid derivatives) to extend processing windows and prevent premature crosslinking during compounding 13, and multi-stage foaming protocols where initial low-temperature expansion (170–180°C) creates fine cell nuclei, followed by high-temperature growth (200–210°C) to achieve uniform cell size distributions (coefficient of variation <20%) 2.
Continuous extrusion foaming enables high-volume production of EVA foam sheets, profiles, and tubes for packaging applications 57:
Melt Preparation: EVA compound is fed into a single- or twin-screw extruder with multiple heating zones (barrel temperatures 120–180°C), where shear mixing homogenizes the melt and activates crosslinking agents.
Blowing Agent Injection: Chemical blowing agents are pre-mixed with the resin, or physical blowing agents (CO₂, nitrogen) are injected into the melt stream at 10–20 MPa pressure to create a supersaturated polymer-gas solution.
Die Extrusion And Expansion: The pressurized melt is extruded through a shaped die into ambient pressure, causing instantaneous gas nucleation and foam expansion. Die temperature (160–190°C) and die gap geometry control foam density and surface finish. Patent 5 describes a method for producing high-density polyethylene foam (0.1–0.5 g/cm³) with optional EVA addition (5–20 wt%) using an adiabatic extruder where vortex pressure between screw tip and screen is maintained constant, and screen temperature is kept 10–20°C lower than screw temperature to prevent premature blowing agent decomposition.
Calibration And Cooling: Extruded foam passes through sizing dies or vacuum calibration tables to achieve dimensional tolerances (±0.5 mm for packaging inserts), followed by water or air cooling to solidify the cell structure.
Advantages of extrusion foaming include continuous production, minimal material waste (<5%), and the ability to co-extrude multi-layer structures (e.g., EVA foam core with polyolefin skin layers for enhanced barrier properties) 520. Patent 20 discloses a multi-layered gliding board structure comprising a polyethylene/EVA foam core (0.15–0.3 g/cm³ density) laminated with an ethylene-octene plastomer intermediate layer (50–150 μm thickness) and a polyolefin graphic film, achieving improved bonding strength (>5 N/cm peel strength) and surface smoothness (Ra <2 μm) for packaging applications requiring printed graphics.
Injection molding of EVA foam enables production of complex three-dimensional packaging components such as corner protectors, electronic device enclosures, and medical equipment cases 6718:
Injection Molding: EVA foam compounds with controlled melt viscosity (500–20,000 cP at 190°C per ASTM D1084) are injected into heated molds (140–170°C) at 50–150 MPa pressure, where in-mold foaming occurs as blowing agents decompose and the part expands to fill the cavity 613. Patent 6 describes low-density EVA foams (0.06–0.18 g/cm³) for medical applications produced by blending EVA resin with ethylene methyl acrylate (EMA) copolymer (10–30 wt%) to improve injection molding characteristics, reducing shrinkage from 8–12% (pure EVA) to 3–5% (EVA/EMA blend) and enhancing biocompatibility (cytotoxicity grade 0–1 per ISO 10993-5).
Rotational Molding: Patent 7 introduces a novel method for producing large-volume EVA/polyethylene foam packaging (e.g., protective cases, flotation devices) using rotational molding equipment. The process involves loading EVA/PE powder blend (particle size 200–500 μm) with blowing agent into a rotating mold, heating to 180–220°C (above blowing agent decomposition temperature) while rotating biaxially at 4–20 rpm, allowing uniform foam formation on mold walls, and cooling under continued rotation to prevent warping. This method eliminates size and shape limitations of compression molding and enables production of hollow foam structures with wall thicknesses of 5–50 mm and densities of 0.08–0.25 g/cm³.
The performance of ethylene vinyl acetate packaging foam in protective packaging applications is defined by a comprehensive set of physical, mechanical, and thermal properties that must be optimized for specific end-use requirements 126810.
Density Range: EVA packaging foams span densities from 0.01 g/cm³ (ultra-soft cushioning) to 0.5 g/cm³ (structural packaging), with the majority of commercial products in the 0.05–0.3 g/cm³ range 2618. Density directly correlates with compression strength, energy absorption, and material cost: reducing density from 0.2 to 0.1 g/cm³ decreases compression strength at 25% strain from 150 kPa to 50 kPa but improves cushioning efficiency (energy absorbed per unit stress) by 40–60% 2.
Cell Morphology: Closed-cell content typically exceeds 90% in well-processed EVA foams, providing moisture resistance (water absorption <5% by volume after 24-hour immersion per ASTM D2842) and dimensional stability 10. Average cell diameter ranges from 10 to 300 μm, with finer cells (<50 μm) yielding smoother surface finish and higher compression strength, while coarser cells (>150 μm) offer better flexibility and lower density 10. Patent 10 specifies that EVA foam particles with bulk density of 15–500 g/L and cell diameters of 10–300 μm, exhibiting 2–3 endothermic peaks in DSC heating scans (10°C/min from 0 to 200°C), demonstrate excellent impact resistance (>80% energy return in rebound tests) and low compression set (<15% after 22 hours at 50°C).
Hardness: Shore 00 hardness of 10–60 for ultra-soft foams (cushioning, comfort applications) and Shore A hardness of 20–75 for firmer structural foams (load-bearing packaging) 218. Patent 2 achieves Shore 00 hardness of 10–60 with densities of 0.01–0.06 g/cm³ by using 2–18 phr blowing agent and optimizing crosslinking density to balance softness and resilience.
Tensile Strength And Elongation: Tensile strength ranges from 0.3 MPa (ultra-soft foams) to 3.5 MPa (high-density structural foams), with elongation at break of 150–500% depending on
| Org | Application Scenarios | Product/Project | Technical Outcomes |
|---|---|---|---|
| SEALED AIR CORPORATION | Protective packaging for electronics, consumer goods, and fragile items requiring impact absorption and cushioning with controlled density and cell structure uniformity. | EVA Foam Packaging Materials | Melt index greater than 1 g/10 min with 5-25 wt% vinyl acetate content, enabling superior processability and dimensional stability for protective packaging applications. |
| Braskem S.A. | Comfort cushioning applications, medical device padding, and lightweight protective packaging requiring ultra-soft touch and high resilience under repeated loading cycles. | Ultra-Soft EVA Foam | Achieves 0.01-0.06 g/cm³ density with 10-60 Shore 00 hardness using 2-18 phr blowing agent and 0.3-4 phr crosslinking agent, providing exceptional softness and compression set resistance below 25% after 22 hours at 70°C. |
| COMTECH CHEMICAL CO. LTD. | Medical and healthcare applications including orthopedic supports, prosthetic padding, and biocompatible device enclosures requiring lightweight protection and human body compatibility. | Low-Density EVA Medical Foam | EVA/EMA blend achieves 0.06-0.18 g/cm³ density with reduced shrinkage from 8-12% to 3-5%, enhanced biocompatibility (cytotoxicity grade 0-1 per ISO 10993-5), and superior injection molding characteristics. |
| ASAHI KASEI CORP | Structural packaging components, automotive interior parts, and outdoor applications requiring high stiffness, thermal stability, and resistance to environmental degradation. | High-Performance EVA Copolymer | Contains 3.0-11.0 mass% vinyl acetate with optimized molecular mobility (compositional ratio α of 28.0-36.0%, relaxation time Tγ of 375-600 μs), delivering flexural moduli of 1.2-2.5 GPa at 23°C with excellent weatherability and foaming uniformity. |
| Welli Bins Co. | Sustainable organizational bins, washable storage containers, and eco-friendly consumer packaging requiring bio-based content, durability, and environmental compliance with REACH standards. | Bio-Based EVA Foam Organizational Products | Comprises 65-70% bio-based EVA resin from sugarcane with 2-8% natural cellulose fiber, achieving 0.3 g/cm³ density and 65-75 durometer (Asker-C), providing washable, durable, and sustainable packaging solutions with minimal-waste injection molding process. |